CANNABIS SATIVA SUBSP. INDICA TOP\DEVICE: 27 Adverse Event Reports & Safety Profile
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
27
Total FAERS Reports
0
Deaths Reported
13
Hospitalizations
27
As Primary/Secondary Suspect
5
Life-Threatening
3
Disabilities
First Report: 20180928 · Latest Report: 20240501
What Are the Most Common CANNABIS SATIVA SUBSP. INDICA TOP\DEVICE Side Effects?
#1 Most Reported
Dyspnoea
8 reports (29.6%)
#2 Most Reported
Cough
7 reports (25.9%)
#3 Most Reported
Pyrexia
6 reports (22.2%)
All CANNABIS SATIVA SUBSP. INDICA TOP\DEVICE Side Effects by Frequency
| Side Effect | Reports | % of Total | Deaths | Hosp. |
|---|---|---|---|---|
| Dyspnoea | 8 | 29.6% | 0 | 5 |
| Cough | 7 | 25.9% | 0 | 4 |
| Pyrexia | 6 | 22.2% | 0 | 5 |
| Nausea | 5 | 18.5% | 0 | 3 |
| Substance use | 5 | 18.5% | 0 | 3 |
Who Reports CANNABIS SATIVA SUBSP. INDICA TOP\DEVICE Side Effects? Age & Gender Data
Gender: 24.0% female, 76.0% male. Average age: 26.0 years. Most reports from: US. View detailed demographics →
Is CANNABIS SATIVA SUBSP. INDICA TOP\DEVICE Getting Safer? Reports by Year
| Year | Reports | Deaths | Hosp. |
|---|---|---|---|
| 2018 | 1 | 0 | 1 |
| 2019 | 5 | 0 | 5 |
| 2020 | 3 | 0 | 2 |
| 2024 | 1 | 0 | 0 |
Official FDA Label for CANNABIS SATIVA SUBSP. INDICA TOP\DEVICE
Official prescribing information from the FDA-approved drug label.